abstract: Bloodstream infections (BSI) are among the most frequent complications in neutropenic cancer patients and, if caused by Gram-negative rods, are associated with high mortality. Thus, fever during neutropenia warrants prompt empirical antibiotic therapy which should be active against the most frequent Gram-negatives. In the last decade,...
-
2016 (v1)PublicationUploaded on: April 14, 2023
-
2016 (v1)Publication
Multidrug-resistant (MDR) bacteria, particularly Gram negatives, such as Enterobacteriaceae resistant to third-generation cephalosporins or carbapenems and MDR Pseudomonas aeruginosa, are increasingly frequent in hematology patients. The prevalence of different resistant species varies significantly between centers. Thus, the knowledge of local...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
Purpose of reviewHHV-8-associated diseases are rare but potentially fatal in transplant recipients. Important differences exist in the distribution of HHV-8 seroprevalence, which might contribute to the lack of uniform approach to HHV-8. The aim of this review was to discuss recent updates in screening and management of HHV-8 after...
Uploaded on: February 11, 2024 -
2022 (v1)Publication
No description
Uploaded on: February 11, 2024 -
2021 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2018 (v1)Publication
Introduction: The emergence and diffusion of multidrug-resistant Gram-negative bacteria (MDR-GNB) is an unprecedented threat, with prevalences as high as 10–50% being reported in many countries. Areas covered: In the present review, we discuss the management of infections due to MDR-GNB, focusing in particular on current strategies and novel...
Uploaded on: April 14, 2023 -
2022 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2018 (v1)Publication
Infection with HBV and HCV represents a growing challenge in the management of patients with hematological malignancies. Recently, hepatitis E (HEV) was recognized as an endemic infection in developed countries and as an emerging health problem in immunocompromised patients. Areas covered: We reviewed the current knowledge on the impact of...
Uploaded on: April 14, 2023